Mitochondrial dysfunction in bipolar disorder: Evidence, pathophysiology and translational implications

  title={Mitochondrial dysfunction in bipolar disorder: Evidence, pathophysiology and translational implications},
  author={Giselli Scaini and Gislaine Tezza Rezin and Andr{\'e} Ferrer Carvalho and Em{\'i}lio Luiz Streck and Michael Berk and Jo{\~a}o Quevedo},
  journal={Neuroscience \& Biobehavioral Reviews},

Figures and Tables from this paper

The Role of Mitonuclear Incompatibility in Bipolar Disorder Susceptibility and Resilience Against Environmental Stressors

Vigorous evidence supports the role of mitochondrial dysfunction in the etiology of bipolar disorder, including dysregulated oxidative phosphorylation, general decrease of energy, altered brain bioenergetics, co-morbidity with mitochondrial disorders, and association with genetic variants in mitochondrial DNA (mtDNA) or nuclear-encoded mitochondrial genes.

The Role of Mitochondria in Mood Disorders: From Physiology to Pathophysiology and to Treatment

A focused narrative review of the currently available evidence supporting the involvement of mitochondrial dysfunction in mood disorders, the effects of current therapies on mitochondrial functions, and novel targeted therapies acting on mitochondrial pathways that might be useful for the treatment of mood disorders are provided.

Concepts of Neuroinflammation and Their Relationship With Impaired Mitochondrial Functions in Bipolar Disorder

A deeper understanding of BD pathophysiology and identification of associated biomarkers of neuroinflammation are needed to facilitate early diagnosis and treatment of this debilitating disorder.

Therapeutic Interventions to Mitigate Mitochondrial Dysfunction and Oxidative Stress–Induced Damage in Patients with Bipolar Disorder

A better understanding of the roles of OS, mitochondrial dysfunction, and inflammation in the pathogenesis of bipolar disorder, along with a stronger elucidation of the therapeutic functions of antioxidants, antipsychotics, anti-inflammatory agents, lithium therapy, and light therapies, may lead to improved strategies for the treatment and prevention ofipolar disorder.

Lithium and the Interplay Between Telomeres and Mitochondria in Bipolar Disorder

This review integrates the current understanding of mitochondrial dysfunction, oxidative stress and telomere shortening in bipolar disorder with documented effects of lithium and proposes that lithium’s mechanism of action is intimately connected with the interdependent regulation of mitochondrial bioenergetics andtelomere maintenance.

The Neurobiology of Bipolar Disorder.

Bipolar disorders are severe and have a high prevalence; despite this, the neurobiological mechanisms are far from being elucidated, and this limits the development of new treatments. Although the

Neurobiology of bipolar disorders: a review of genetic components, signaling pathways, biochemical changes, and neuroimaging findings

Genetic, epigenetic, molecular, physiological, clinical, environmental data, and neuroimaging findings associated with the neurobiology of bipolar disorder are discussed.



Mitochondrial dysfunction in the pathophysiology of bipolar disorder: effects of pharmacotherapy.

Current research on the interactions between mitochondrial dysfunction and bipolar disorder pathology is evaluated, the current literature describing the effects of bipolar disorder drugs on mitochondrial function is appraised, and ramifications for future research are discussed.

Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia

Mitochondrial dysfunction in bipolar disorder.

The mitochondrial dysfunction hypothesis, which comprehensively accounts for the pathophysiology of bipolar disorder, is proposed and it is found that 5178C and 10398A polymorphisms in mtDNA were risk factors for bipolar disorder.

Mitochondrially Mediated Plasticity in the Pathophysiology and Treatment of Bipolar Disorder

It is proposed that although BPD is not a classic mitochondrial disease, subtle deficits in mitochondrial function likely play an important role in various facets of BPD, and that enhancing mitochondrial function may represent a critical component for the optimal long-term treatment of the disorder.

Molecular evidence for mitochondrial dysfunction in bipolar disorder.

Findings point toward a widespread dysregulation of mitochondrial energy metabolism and downstream deficits of adenosine triphosphate-dependent processes in bipolar disorder.

Abnormalities in mitochondrial structure in cells from patients with bipolar disorder.

The observed changes in mitochondrial size and distribution may be linked to energy deficits and, therefore, may have consequences for cell plasticity, resilience, and survival in patients with BD, especially in brain, which has a high-energy requirement.

Mitochondrial modulators for bipolar disorder: A pathophysiologically informed paradigm for new drug development

Converting data implicate mitochondrial dysfunction as an important component of the pathophysiology of bipolar disorder and clinical trials of individual MMs as well as combinations are warranted.

Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder.

Impairment of complex I may be associated with increased protein oxidation and nitration in the prefrontal cortex of patients with bipolar disorder, and complex I activity and mitochondrial dysfunction may be potential therapeutic targets for bipolar disorder.

Mitochondrial dysfunction and molecular pathways of disease.